Investor profile

Lexi Ventures logo

Lexi Ventures

VC

USBio/PharmaDeep TechHealthtech

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Lexi Ventures is Genetic Engineering Capital. We believe the genetic engineering revolution will be one of the most value-creating venture categories in the next decade. Biology has turned from science to engineering. Gene tech now allows us to read, write, and edit the code of life with unprecedented precision and scale. We provide seed funding for US-based companies building around DNA, RNA, Cells, and 'Omics. We invest in the engineers and startups aiming to cure many of the worst and most expensive diseases, improving happiness and reducing healthcare needs, and enable plants and microbes to produce new kinds of products while sustaining the natural environment.

Notable quotes

I founded Lexi Ventures to invest in genetics, humanity's most powerful technology

Jonah Probell · LinkedIn

Biology is software. It has officially turned from science to engineering, allowing us to read, write, and edit the code of life with unprecedented precision and scale.

Jonah Probell · LinkedIn

Team

Jonah Probell

Founder & Managing Partner

Bio/PharmaDeep TechHealthtech

Recent investments

CompanyRoundSizeDate
Kopra BioSeed$9m
ParcelBioSeed$13m2026-02-06
KiraGenSeed
QUiCKR BioSeed
MelioSeed
AlkaLi LabsSeed
Glyphic BioSeed
SyntensorSeed
TippingPointSeed
Taxa TechnologiesSeed

Frequent co-investors

VC firmDeals together
Y Combinator2
Metaplanet2
Breyer Capital1
General Catalyst1
Pioneer Fund1
Singularity Capital1

Fit check

Is Lexi Ventures a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit